K

Kaya Ltd
NSE:KAYA

Watchlist Manager
Kaya Ltd
NSE:KAYA
Watchlist
Price: 328.25 INR -4.86% Market Closed
Market Cap: ₹5B

Kaya Ltd
Investor Relations

Kaya Ltd. provides health care aesthetics, beauty and personal care products and services. The company is headquartered in Mumbai, Maharashtra and currently employs 605 full-time employees. The company went IPO on 2015-08-14. The firm offers specialty products and services, which are developed by its dermatologists. The company provides a range of skin and hair care products and services, such as remedying acne, pigmentation, dull skin concerns, overall skin health, hair concerns and other everyday skin and hair needs. The firm offers approximately 80+ products, including acne, brightening, everyday essentials, anti-ageing, derma naturals, body care, hair care and beauty facials. Its skin- and hair-based services include Oxygeneo Medifacial, Skin and Eye Threads, Profhilo Fillers, Restylane Lyft, Restylane Kysse, High-intensity focused ultrasound, and Hair threads. Its Body care portfolio includes CoolSculpting Technology, Enzymatic Resurfacing, Venus Legacy and Happy Intim intimate rejuvenation. Its skin care portfolio includes IV Boost, DNA Repair Therapy and Skin Boosters Jalupro.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Aug 6, 2025
AI Summary
Q1 2026

Revenue Growth: Kaya's clinic business collections grew 7% year-on-year, while overall revenue from operations rose 1% to INR 52.8 crores in Q1 FY '26.

Profitability Drop: The company posted a stand-alone loss after tax of INR 14.2 crores versus a profit of INR 6.4 crores last year, which included a one-time gain.

Product & Service Mix: The product business grew 11% and the services business grew 6%, with strong momentum in categories like Bath & Body, Nutraceuticals, Sun Care, Hair Care, and Pigmentation.

Expansion & Investment: Opened 2 new clinics and invested in 31 new dermatology machines as part of ongoing brand refresh and innovation efforts.

Fundraising Update: Shifted from a planned rights issue to a preferential allotment of INR 75 crores for faster capital raising, with the rights issue still under consideration.

Customer Experience: NPS score remained high at 90, and over 90% of collections came from the Kaya Smiles loyalty program.

Key Financials
Revenue from Operations
INR 52.8 crores
Clinic Business Collection Growth
7%
Clinic Product Business Growth
11%
Services Business Collection Growth
6%
Hair Care Growth
20%
Brightening and Pigmentation Growth
13%
NPS Score
90
Loss After Tax
negative INR 14.2 crores
Kaya Smiles Loyalty Program Contribution
more than 90% of clinic collections
Service vs. Product Revenue Split
Services 85%, Products 15%
New Customer Count
up 6%
Other Earnings Calls

Management

Dr. Harshraj Charandas Mariwala
Chairman & MD
No Bio Available
Mr. Arihant Dhariwal
Chief Financial Officer
No Bio Available
Ms. Nitika Sunny Dalmia
Company Secretary & Compliance Officer
No Bio Available
Mr. Rajiv Suri
Global CEO & MD of Kaya Middle East
No Bio Available
Mr. Nishant Nayyar
VP & Head of Marketing
No Bio Available
Ms. Amrita Chowdhury
VP & Head of Human Resources
No Bio Available
Dr. Aparna Santhanam
Head Medical Operations
No Bio Available
Mr. Lokesh Wagadre
VP and Head of Information &Technology
No Bio Available

Contacts

Address
MAHARASHTRA
Mumbai
23/C, Mahal Industrial Estate,, Mahakali Caves Road,, Near Paperbox Lane, Andheri (East)
Contacts